Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 Jun 29;16(1):179. doi: 10.1186/s12967-018-1552-1.

2.

First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.

Liau LM, Ashkan K, Tran DD, Campian JL, Trusheim JE, Cobbs CS, Heth JA, Salacz M, Taylor S, D'Andre SD, Iwamoto FM, Dropcho EJ, Moshel YA, Walter KA, Pillainayagam CP, Aiken R, Chaudhary R, Goldlust SA, Bota DA, Duic P, Grewal J, Elinzano H, Toms SA, Lillehei KO, Mikkelsen T, Walbert T, Abram SR, Brenner AJ, Brem S, Ewend MG, Khagi S, Portnow J, Kim LJ, Loudon WG, Thompson RC, Avigan DE, Fink KL, Geoffroy FJ, Lindhorst S, Lutzky J, Sloan AE, Schackert G, Krex D, Meisel HJ, Wu J, Davis RP, Duma C, Etame AB, Mathieu D, Kesari S, Piccioni D, Westphal M, Baskin DS, New PZ, Lacroix M, May SA, Pluard TJ, Tse V, Green RM, Villano JL, Pearlman M, Petrecca K, Schulder M, Taylor LP, Maida AE, Prins RM, Cloughesy TF, Mulholland P, Bosch ML.

J Transl Med. 2018 May 29;16(1):142. doi: 10.1186/s12967-018-1507-6. Erratum in: J Transl Med. 2018 Jun 29;16(1):179.

3.

Metabolomic signature of brain cancer.

Pandey R, Caflisch L, Lodi A, Brenner AJ, Tiziani S.

Mol Carcinog. 2017 Nov;56(11):2355-2371. doi: 10.1002/mc.22694. Epub 2017 Jul 17. Review.

PMID:
28618012
4.

Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors.

Beg MS, Brenner AJ, Sachdev J, Borad M, Kang YK, Stoudemire J, Smith S, Bader AG, Kim S, Hong DS.

Invest New Drugs. 2017 Apr;35(2):180-188. doi: 10.1007/s10637-016-0407-y. Epub 2016 Dec 5.

5.

5,10b-Ethanophenanthridine amaryllidaceae alkaloids inspire the discovery of novel bicyclic ring systems with activity against drug resistant cancer cells.

Henry S, Kidner R, Reisenauer MR, Magedov IV, Kiss R, Mathieu V, Lefranc F, Dasari R, Evidente A, Yu X, Ma X, Pertsemlidis A, Cencic R, Pelletier J, Cavazos DA, Brenner AJ, Aksenov AV, Rogelj S, Kornienko A, Frolova LV.

Eur J Med Chem. 2016 Sep 14;120:313-28. doi: 10.1016/j.ejmech.2016.05.004. Epub 2016 May 6.

6.

Obesity Suppresses Estrogen Receptor Beta Expression in Breast Cancer Cells via a HER2-Mediated Pathway.

Bowers LW, Wiese M, Brenner AJ, Rossi EL, Tekmal RR, Hursting SD, deGraffenried LA.

PLoS One. 2015 Dec 28;10(12):e0145452. doi: 10.1371/journal.pone.0145452. eCollection 2015.

7.

Fungal metabolite ophiobolin A as a promising anti-glioma agent: In vivo evaluation, structure-activity relationship and unique pyrrolylation of primary amines.

Dasari R, Masi M, Lisy R, Ferdérin M, English LR, Cimmino A, Mathieu V, Brenner AJ, Kuhn JG, Whitten ST, Evidente A, Kiss R, Kornienko A.

Bioorg Med Chem Lett. 2015 Oct 15;25(20):4544-8. doi: 10.1016/j.bmcl.2015.08.066. Epub 2015 Aug 24.

8.

VB-111: a novel anti-vascular therapeutic for glioblastoma multiforme.

Gruslova A, Cavazos DA, Miller JR, Breitbart E, Cohen YC, Bangio L, Yakov N, Soundararajan A, Floyd JR, Brenner AJ.

J Neurooncol. 2015 Sep;124(3):365-72. doi: 10.1007/s11060-015-1853-7. Epub 2015 Jun 25.

9.

Hypoxia in astrocytic tumors and implications for therapy.

Cavazos DA, Brenner AJ.

Neurobiol Dis. 2016 Jan;85:227-233. doi: 10.1016/j.nbd.2015.06.007. Epub 2015 Jun 19. Review.

10.

Activity of 2-aryl-2-(3-indolyl)acetohydroxamates against drug-resistant cancer cells.

Aksenov AV, Smirnov AN, Magedov IV, Reisenauer MR, Aksenov NA, Aksenova IV, Pendleton AL, Nguyen G, Johnston RK, Rubin M, De Carvalho A, Kiss R, Mathieu V, Lefranc F, Correa J, Cavazos DA, Brenner AJ, Bryan BA, Rogelj S, Kornienko A, Frolova LV.

J Med Chem. 2015 Mar 12;58(5):2206-20. doi: 10.1021/jm501518y. Epub 2015 Feb 20.

11.

Obesity-associated systemic interleukin-6 promotes pre-adipocyte aromatase expression via increased breast cancer cell prostaglandin E2 production.

Bowers LW, Brenner AJ, Hursting SD, Tekmal RR, deGraffenried LA.

Breast Cancer Res Treat. 2015 Jan;149(1):49-57. doi: 10.1007/s10549-014-3223-0. Epub 2014 Dec 5.

12.

NSAID use reduces breast cancer recurrence in overweight and obese women: role of prostaglandin-aromatase interactions.

Bowers LW, Maximo IX, Brenner AJ, Beeram M, Hursting SD, Price RS, Tekmal RR, Jolly CA, deGraffenried LA.

Cancer Res. 2014 Aug 15;74(16):4446-57. doi: 10.1158/0008-5472.CAN-13-3603.

13.

Protein imprinting in polyacrylamide-based gels.

Zayats M, Brenner AJ, Searson PC.

Biomaterials. 2014 Oct;35(30):8659-68. doi: 10.1016/j.biomaterials.2014.05.079. Epub 2014 Jul 14.

14.

Image-guided interventional therapy for cancer with radiotherapeutic nanoparticles.

Phillips WT, Bao A, Brenner AJ, Goins BA.

Adv Drug Deliv Rev. 2014 Sep 30;76:39-59. doi: 10.1016/j.addr.2014.07.001. Epub 2014 Jul 9. Review.

15.

Obesity enhances nongenomic estrogen receptor crosstalk with the PI3K/Akt and MAPK pathways to promote in vitro measures of breast cancer progression.

Bowers LW, Cavazos DA, Maximo IX, Brenner AJ, Hursting SD, deGraffenried LA.

Breast Cancer Res. 2013;15(4):R59.

16.

Phase I dose-escalation study of VB-111, an antiangiogenic virotherapy, in patients with advanced solid tumors.

Brenner AJ, Cohen YC, Breitbart E, Bangio L, Sarantopoulos J, Giles FJ, Borden EC, Harats D, Triozzi PL.

Clin Cancer Res. 2013 Jul 15;19(14):3996-4007. doi: 10.1158/1078-0432.CCR-12-2079. Epub 2013 Apr 15.

17.

KDM1 is a novel therapeutic target for the treatment of gliomas.

Sareddy GR, Nair BC, Krishnan SK, Gonugunta VK, Zhang QG, Suzuki T, Miyata N, Brenner AJ, Brann DW, Vadlamudi RK.

Oncotarget. 2013 Jan;4(1):18-28.

18.

Rhenium-186 liposomes as convection-enhanced nanoparticle brachytherapy for treatment of glioblastoma.

Phillips WT, Goins B, Bao A, Vargas D, Guttierez JE, Trevino A, Miller JR, Henry J, Zuniga R, Vecil G, Brenner AJ.

Neuro Oncol. 2012 Apr;14(4):416-25. doi: 10.1093/neuonc/nos060. Epub 2012 Mar 16.

19.

The enhancing effects of obesity on mammary tumor growth and Akt/mTOR pathway activation persist after weight loss and are reversed by RAD001.

De Angel RE, Conti CJ, Wheatley KE, Brenner AJ, Otto G, Degraffenried LA, Hursting SD.

Mol Carcinog. 2013 Jun;52(6):446-58. doi: 10.1002/mc.21878. Epub 2012 Jan 30.

PMID:
22290600
20.

The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cells.

Vo DT, Abdelmohsen K, Martindale JL, Qiao M, Tominaga K, Burton TL, Gelfond JA, Brenner AJ, Patel V, Trageser D, Scheffler B, Gorospe M, Penalva LO.

Mol Cancer Res. 2012 Jan;10(1):143-55. doi: 10.1158/1541-7786.MCR-11-0208.

21.

Powered bone marrow biopsy procedures produce larger core specimens, with less pain, in less time than with standard manual devices.

Miller LJ, Philbeck TE, Montez DF, Puga TA, Brodie KE, Cohen SC, Spadaccini C, Swords R, Brenner AJ.

Hematol Rep. 2011 Jan 13;3(1):e8. doi: 10.4081/hr.2011.e8. Epub 2011 Jun 18.

22.

The oncogenic RNA-binding protein Musashi1 is regulated by tumor suppressor miRNAs.

Vo DT, Qiao M, Smith AD, Burns SC, Brenner AJ, Penalva LO.

RNA Biol. 2011 Sep-Oct;8(5):817-28. doi: 10.4161/rna.8.5.16041. Epub 2011 Sep 1.

PMID:
21881409
23.

A prospective randomised study of a rotary powered device (OnControl) for bone marrow aspiration and biopsy.

Swords RT, Anguita J, Higgins RA, Yunes AC, Naski M, Padmanabhan S, Kelly KR, Mahalingam D, Philbeck T, Miller L, Puga TA, Giles FJ, Kinney MC, Brenner AJ.

J Clin Pathol. 2011 Sep;64(9):809-13. doi: 10.1136/jclinpath-2011-200047. Epub 2011 May 23.

PMID:
21606230
24.

Common toxicities of mammalian target of rapamycin inhibitors.

Soefje SA, Karnad A, Brenner AJ.

Target Oncol. 2011 Jun;6(2):125-9. doi: 10.1007/s11523-011-0174-9. Epub 2011 Apr 16. Review.

PMID:
21499766
25.

Rotary powered device for bone marrow aspiration and biopsy yields excellent specimens quickly and efficiently.

Swords RT, Kelly KR, Cohen SC, Miller LJ, Philbeck TE, Hacker SO, Spadaccini CJ, Giles FJ, Brenner AJ.

J Clin Pathol. 2010 Jun;63(6):562-5. doi: 10.1136/jcp.2009.072843. Epub 2010 Apr 19.

PMID:
20404008
26.

WWOX, the FRA16D gene, behaves as a suppressor of tumor growth.

Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM.

Cancer Res. 2001 Nov 15;61(22):8068-73.

28.

Analysis of telomerase activity levels in breast cancer: positive detection at the in situ breast carcinoma stage.

Bednarek AK, Sahin A, Brenner AJ, Johnston DA, Aldaz CM.

Clin Cancer Res. 1997 Jan;3(1):11-6.

29.

The genetics of sporadic breast cancer.

Brenner AJ, Aldaz CM.

Prog Clin Biol Res. 1997;396:63-82. Review.

PMID:
9108590
30.

Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.

Brenner AJ, Paladugu A, Wang H, Olopade OI, Dreyling MH, Aldaz CM.

Clin Cancer Res. 1996 Dec;2(12):1993-8.

32.

A quantitative test for copper using bicinchoninic acid.

Brenner AJ, Harris ED.

Anal Biochem. 1995 Mar 20;226(1):80-4. Erratum in: Anal Biochem 1995 Sep 20;230(2):360.

PMID:
7785783
33.

Trials and tribulations in the treatment of intestinal parasitic disease.

BRENNER AJ.

Am J Gastroenterol. 1961 Nov;36:570-81. No abstract available.

PMID:
13872821
34.

Spasm direct and indirect.

BERNSTEIN BM, BRENNER AJ, BERNSTEIN JS, BERNSTEIN BP.

Am J Gastroenterol. 1961 Oct;36:459-63. No abstract available.

PMID:
13868253
35.

Primary lymphosarcoma of the stomach: fifteen years after surgery and radiation.

TESLER J, BRENNER AJ.

Am J Gastroenterol. 1959 Nov;32:557-64. No abstract available.

PMID:
13837565
36.

Present status of gastric cytology; a study of 60 cases by the chymotrypsin method.

BRENNER AJ, KORNSTEIN A, BANDLER M, MATZNER MJ.

Am J Gastroenterol. 1958 Oct;30(4):415-24. No abstract available.

PMID:
13571211
37.

Lymphatic leukemia complicated by carcinoma of the stomach.

BRENNER AJ, EPSTEIN BS.

Am J Gastroenterol. 1956 Feb;25(2):116-24. No abstract available.

PMID:
13282873
38.

Scleroderma with gastrointestinal involvement.

BRENNER AJ.

Rev Gastroenterol. 1947 Dec;14(12):869-72. No abstract available.

PMID:
18895650

Supplemental Content

Loading ...
Support Center